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Abstract
Background: Nucleotide pyrophosphatase/phosphodiesterase 7 (NPP7) is the only member of the mammalian
NPP enzyme family that has been confirmed to act as a sphingomyelinase, hydrolyzing sphingomyelin (SM) to
form phosphocholine and ceramide. NPP7 additionally hydrolyzes lysophosphatidylcholine (LPC), a substrate
preference shared with the NPP2/autotaxin(ATX) and NPP6 mammalian family members. This study utilizes a
synergistic combination of molecular modeling validated by experimental site-directed mutagenesis to explore the
molecular basis for the unique ability of NPP7 to hydrolyze SM.
Results: The catalytic function of NPP7 against SM, LPC, platelet activating factor (PAF) and para-
nitrophenylphosphorylcholine (pNPPC) is impaired in the F275A mutant relative to wild type NPP7, but different
impacts are noted for mutations at other sites. These results are consistent with a previously described role of F275
to interact with the choline headgroup, where all substrates share a common functionality. The L107F mutation
showed enhanced hydrolysis of LPC, PAF and pNPPC but reduced hydrolysis of SM. Modeling suggests this
difference can be explained by the gain of cation-pi interactions with the choline headgroups of all four substrates,
opposed by increased steric crowding against the sphingoid tail of SM. Modeling also revealed that the long and
flexible hydrophobic tails of substrates exhibit considerable dynamic flexibility in the binding pocket, reducing the
entropic penalty that might otherwise be incurred upon substrate binding.
Conclusions: Substrate recognition by NPP7 includes several important contributions, ranging from cation-pi
interactions between F275 and the choline headgroup of all substrates, to tail-group binding pockets that
accommodate the inherent flexibility of the lipid hydrophobic tails. Two contributions to the unique ability of NPP7 to
hydrolyze SM were identified. First, the second hydrophobic tail of SM occupies a second hydrophobic binding pocket.
Second, the leucine residue present at position 107 contrasts with a conserved phenylalanine in NPP enzymes that do
not utilize SM as a substrate, consistent with the observed reduction in SM hydrolysis by the NPP7-L107F mutant.
Background
The nucleotide pyrophosphatase/phosphodiesterase
(NPP) enzymes are classified as pyrophosphatases or
phosphodiesterases depending on the type of substrates
they hydrolyze. NPP1-3 are pyrophosphatases that
cleave inorganic phosphates from nucleotides and their
derivatives [1]. In contrast, NPP2, NPP6 and NPP7 are
phosphodiesterases that hydrolyze phosphodiester bonds
in lipids and their derivatives [2,3]. NPP4 and NPP5 are
yet to be characterized in terms of substrates and types
of activity. NPP2 is the only one of the seven mamma-
lian NPP family members that is known to possess both
pyrophosphatase and phosphodiesterase activities [4].
NPP2 is also the only mammalian family member to
have been characterized by X-ray crystallography [5,6].
As a phosphodiesterase it exhibits a lysophospholipase
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exhibit lysophospholipase C (LPLC) activity. Besides
these specific activities, NPP family members also exhi-
bit distinct substrate preference profiles but no clear
structural basis for the preferences has been proposed
[1]. NPP family members are of considerable interest
due to their role in biological functions ranging from
bone mineralization to cancer [4,7,8]. NPP7 specifically
has been linked with anti-inflammatory and anti-tumori-
genic activities through its influence on the conversion
of SM to ceramide [9-11], however homozygous knock-
o u to fN P P 7i nm i c ed i dn o tl e a dt os p o n t a n e o u s
tumorigenesis although lipid digestion and absorption
was altered [12]. Mutagenic deletion of a segment from
NPP7 including H353, a residue involved in chelating
one of the essential divalent metal cations, has been
identified in the rapidly proliferating colon cancer HT-
29 cell line [13].
NPP7 hydrolyzes lysophosphatidylcholine (LPC, Figure
1), platelet activating factor (PAF, Figure 1) and sphin-
gomyelin (SM, Figure 1) with a lysophospholipase C
activity but exhibits a preference for SM over LPC and
PAF [10]. Several studies have examined the roles of
specific amino acids in the hydrolysis of SM. Three of
the conserved metal-chelating residues from the NPP
family (D199 and D246 [10,14], as well as H353 [13])
have been mutated to alanine in NPP7, and each mutant
was devoid of sphingomyelinase activity. The conserved
catalytic threonine residue, T75, has also been mutated
to alanine with the expected loss of sphingomyelinase
activity [14]. Additional amino acids near the catalytic
residue have been mutated in attempts to change sub-
strate specificity to include nucleotide pyrophosphates,
including M74K, S76F, and C78N [14]. These mutations
all eliminated sphingomyelinase activity without produ-
cing pyrophosphatase activity. It is unclear whether the
mutated proteins were properly folded, although expres-
sion levels were comparable to wild type. More recently,
mutations based on a comparative model of NPP7 were
performed [15]. In contrast to the result obtained upon
mutation of M74 to K, mutation of M74 to L enhanced
sphingomyelinase activity, again without gain of pyro-
phosphatase activity. The model displayed close interac-
tion between F275 and the choline methyl groups, best
described as a cation-π interaction. Mutation of F275 to
glycine nearly eliminated sphingomyelinase activity. The
model displayed no close interaction between F141 and
substrates, however, the F141S mutation showed activity
nearly as poor as the F275G mutant, indicating either
incorrect selection of the conformation of the loop
involving residues 140-171, or incorrect substrate posi-
tioning. Therefore the interactions between NPP7 and
SM are partially defined, and modeled interactions with
other substrates have not been supported by experimen-
tal results. Further efforts are clearly needed to develop
a complete and coherent picture of substrate recognition
and discrimination by NPP7.
Lyso-platelet activating factor (lyso PAF), sphingosyl-
phosphorylcholine (SPC), and para-nitrophenyphosphor-
ylcholine (pNPPC, Figure 1) are high affinity substrates
for NPP7 (Tables 1, 2, 3 and 4, and [10]). Here we
examine the amino acid residues within the NPP7 active
Figure 1 NPP7 substrate structures.
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NPP7. We employed homology modeling to predict pro-
tein-substrate interaction points followed by experimen-
tal validation of the predictions by mutagenesis and
biochemical assays. We used the bacterial Xac NPP
crystal structure [16] as well as two recently reported
NPP2 crystal structures [5,6] to generate homology
models of NPP7 for this work. Our modeling results
reveal a common choline headgroup binding pocket for
all substrates. The strong interactions between the catio-
nic choline and the π electrons of the aromatic side-
chain of F275 were easily identified by standard docking
algorithms. Experimental mutagenesis results are consis-
tent with the predicted choline headgroup positions for
all substrates. The hydrophobic tails proved more chal-
lenging to place in the complex. Docking algorithms
typically cannot exhaustively search the conformations
and positions of long and flexible molecules lacking any
polar groups that would be involved in directional inter-
actions such as hydrogen bonding. Manual placement
was used, and refinements of hydrophobic tail positions
by molecular dynamics were required in order to corre-
late the substrate complex models with the experimental
mutagenesis results in the hydrophobic tail region. The
molecular dynamics simulations were important to
demonstrate the high mobility of the hydrophobic tail
positions, as well as to refine the initial complex of
sphingomyelin (SM) to explain the different pattern of
experimental mutation impacts on activity for this sub-
strate, relative to the other three examined.
Methods
Molecular modeling
Molecular modeling and simulation was done using the
Molecular Operating Environment (MOE) software
package [17]. Three homology models of NPP7 were
built in MOE by aligning the human protein sequence
[2] (Genbank code AY20633) with either the bacterial
Xac crystal structure from the protein data bank (PDB
[18] entry 2GSO[16]), the rat NPP2 crystal structure
(PDB entry 2XR9[5]) or the mouse NPP2 crystal struc-
ture (PDB entry 3NKM[6]). The homology models were
energy minimized using the MMFF94x force field, a
derivative of the MMFF94 [19] force field with improved
treatment of planar nitrogens. Minimizations were ter-
minated when the energy gradient reached a root mean
square (RMSG) value of 1 kcal/mol·Å in order to pre-
vent collapse of binding pockets to enhance hydropho-
bic interactions in the absence of ligand.
Substrate docking with the MOE software was used to
study interactions between NPP7 and its previously
known substrates and their closely related analogs.
Docking used placements of ligand atom triangles into
protein site alpha sphere triangles with subsequent
Table 1 Kinetic parameters for hydrolysis of LPC 16:0.
Enzyme Km (μM) Vmax (μM/sec)
(× 10
-2)
kcat(sec
-1)k cat/Km (M
-1sec
-1)( ×1 0
4)
L107F 61 ± 2.8 3.5 ± 0.03 4.2 ± 0.03 6.8 ± 1.6
Y142A 69 ± 0.9 3.0 ± 0.01 3.6 ± 0.01 5.2 ± 0.05
Wild type 57 ± 0.7 2.5 ± 0.01 2.9 ± 0.01 5.1 ± 0.1
E169Q 88 ± 6.8 3.3 ± 0.02 3.8 ± 0.03 4.3 ± 0.4
E169A 100 ± 15 1.0 ± 0.04 1.2 ± 0.05 1.2 ± 0.2
F80A 120 ± 3.0 0.7 ± 0.01 1.4 ± 0.01 1.2 ± 0.3
Y166A 100 ± 5.0 0.9 ± 0.03 1.1 ± 0.03 1.0 ± 0.2
F275A No activity
Table 2 Kinetic parameters for hydrolysis of PAF 16:0.
Enzyme Km (μM) Vmax (μM/sec)
(× 10
-2)
kcat (sec
-1)k cat/Km (M
-1sec
-1)( ×1 0
4)
Y142A 75 ± 2 2.0 ± 0.03 2.5 ± 0.04 3.3 ± 0.6
L107F 94 ± 3 2.4 ± 0.3 2.9 ± 0.3 3.1 ± 0.2
Wild type 82 ± 2 1.3 ± 0.02 1.6 ± 0.02 2.0 ± 0.8
E169Q 130 ± 8 1.9 ± 0.1 2.3 ± 0.2 1.7 ± 0.2
F80A 120 ± 3 1.2 ± 0.03 1.4 ± 0.03 1.2 ± 0.4
E169A 95 ± 6 0.8 ± 0.02 0.80 ± 0.02 1.0 ± 0.2
Y166A 200 ± 10 0.7 ± 0.02 0.80 ± 0.04 0.4 ± 0.2
F275A No activity
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initial placements were used in each docking run.
pNPPC was directly docked into the active site as a
whole molecule since it is small and has limited flexibil-
ity. The phospholipid substrates; LPC, PAF, and SM, are
highly flexible because of long hydrocarbon chains in
their structures. For this reason stepwise docking was
done starting with the polar head groups of each sub-
strate. Wall restraints were used to keep the substrate
phosphate within 8 Å of the enzyme’s active residue,
threonine 75. The hydrophobic chains were then
extended three carbon atoms at a time followed by
energy minimization for the newly added atoms at each
step. The protein surface feature within MOE was used
to visualize the various channels that could accommo-
date the substrate hydrophobic tails during binding.
Bond rotations were done on the extended chains fol-
lowed by energy minimization to explore the best posi-
tions for each chain and thus the minimum energy
conformation for each substrate. The lowest energy con-
formation was then selected for each substrate.
Molecular dynamics was performed on selected NPP7
substrate complexes using the MOE software. Simula-
tions were performed using the MMFF94x forcefield
with the Generalized Born implicit solvation model [20].
The NVT ensemble was used with constraints on bonds
to hydrogens. Atomic positions were recalculated at 2 fs
timesteps using the Nosé-Poincairé-Andersen equations
of motion [21,22]. A heating phase of 100 ps was used
to raise the simulation temperature from 0 K to 300 K.
The production phase began at the end of the heating
phase and continued to the 2000 ps timepoint. Snap-
shots were saved every 1 ps during both phases of the
simulation for analysis.
NPP7 Plasmid design
A mammalian expression vector pcDNA4/TO/myc His
B containing the full-length human NPP7 sequence was
a generous gift from Dr. Rui-Dong Duan (Lund Univer-
sity, Sweden). A FLAG-tag and a stop codon were incor-
p o r a t e da tp o s i t i o n4 1 5u s i n gt h es e n s ep r i m e r5 ’-CCC
ATG CTG CAC ACA GAC TAC AAG GAC GAC
GAT GAC AAGTAGGAATCTGCTCTTCCG-3’ and
antisense primer 5’-CGGAAG AGCAGATTCC-
TACTTGTCATCGTCGTCCTTGTAGTCTGTGTG-
CAGCATGGG-3’. This generated NPP7ex-FLAG which
had previously been demonstrated [23] to retain cataly-
tic activity and localize in the cell culture medium.
Mutagenesis was done by PCR using the Quickchange
®
site directed mutagenesis kit from Qiagen-USA. This
customized gene was further sub cloned into the mam-
malian vector, pcDNA3.1 (+) at the NotI and BamHI
restriction sites. All mutants were generated from this
customized plasmid using Qiagen’s multi site-directed
Table 3 Kinetic parameters for hydrolysis of SM.
Enzyme Km (μM) Vmax (μM/sec)
(× 10
-2)
kcat (sec
-1)k cat/Km (M
-1sec
-1)( ×1 0
4)
E169Q 15 ± 5 3.2 ± 0.08 3.8 ± 0.1 25.0 ± 6.0
Y166A 12 ± 0.4 2.6 ± 0.01 3.1 ± 0.2 25.8 ± 5.0
F80A 14 ± 6 2.2 ± 0.3 2.6 ± 0.3 18.6 ± 5.0
Wild type 23 ± 3 3.0 ± 0.1 3.7 ± 0.2 16.5 ± 4.0
E169A 17 ± 2 1.8 ± 0.1 2.2 ± 0.2 11.6 ± 2.0
L107F 37 ± 3 3.5 ± 0.1 4.2 ± 0.1 11.4 ± 4.0
Y142A 47 ± 7 3.1 ± 0.2 3.7 ± 0.2 7.9 ± 3.0
F275A 12 ± 1 0.7 ± 0.1 0.9 ± 0.2 7.5 ± 2.0
Table 4 Kinetic parameters for hydrolysis of pNPPC.
Enzyme Km (μM) Vmax (μM/sec)
(× 10
-2)
kcat (sec
-1)k cat/Km (M
-1sec
-1)( ×1 0
4)
L107F 310 ± 5.0 1.4 ± 0.05 1.7 ± 0.1 0.60 ± 0.02
Wild type 360 ± 8.0 1.1 ± 0.01 1.4 ± 0.1 0.40 ± 0.03
Y142A 400 ± 4.0 1.4 ± 0.01 1.7 ± 0.1 0.40 ± 0.02
F80A 450 ± 10.0 0.63 ± 0.04 0.8 ± 0.1 0.20 ± 0.1
E169A 170 ± 30.0 0.42 ± 0.03 0.5 ± 0.03 0.30 ± 0.02
E169Q 440 ± 5.0 1.2 ± 0.02 1.4 ± 0.1 0.30 ± 0.02
Y166A 820 ± 20.0 0.62 ± 0.03 0.7 ± 0.04 0.09 ± 0.01
F275A 120 ± 5.0 0.23 ± 0.03 0.3 ± 0.03 0.03 ± 0.01
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sense primers used in generating our various mutations
are shown in Table 5. All PCR products were amplified
in Nova blue E. coli cells and purified according to the
manufacturer’s protocols (EMD Chemicals).
NPP7ex-FLAG expression
Human embryonic kidney cells (HEK293T) were seeded
in Dulbecco’s modified Eagle’sm e d i u m( D M E M )c o n -
taining 10% heat inactivated fetal calf serum and 2 mM
L-glutamine. The cells were grown overnight at 37°C
and 5% CO2 up to a 80% confluence before transfection
with purified hNPP7ex-FLAG insert subcloned in the
pcDNA3.1(+) mammalian vector. Transfection was done
in the presence of polyfect transfection reagent from
Qiagen according to the manufacturer’sp r o t o c o l .F i v e
to eight hours after trasfection, the culture medium was
changed to serum free DMEM and cells incubated for
48 hours at 37°C and 5% CO2. Conditioned media con-
taining secreted hNPP7ex-FLAG protein was collected
and concentrated using 10,000 molecular weight cutoff
(MWCO) filters (Millipore, Billerica, MA, USA) by cen-
trifugation at 3000 × g for 20 minutes. Concentrated
NPP7 protein was stored at 4°C in NPP7 assay buffer,
pH 8 without addition of adjuvants.
Western blots
Western blots with the M2 Anti-FLAG antibody (Sigma-
Aldrich, St. Louis, MO, USA) were used to verify
expression of hNPP7ex-FLAG and its mutants by
HEK293T cells. Following Tris-HCl-SDS-PAGE (4-15%)
proteins were transferred onto poly-m-vinylidene
difluoride (PVDF) membrane (Bio-Rad, Hercules, CA,
USA) by electroblotting at 100 V in Tris/Glycine SDS
buffer for 1 hour. Nonspecific binding sites were
blocked in 50 mM Tris buffered saline (TBST: 2.7 mM
KCl, 0.138 M NaCl, 0.5% (v/v) Tween
®20) and 5% (w/v)
non-fat dry milk (NFDM). The membrane was then
treated with Anti-FLAG M2 antibody (Sigma-Aldrich,
USA) (1:2000 in TBST + 3% NFDM) and anti-goat IgG
antibody (Sigma) (1:5000 in TBST + 3% NFDM). Finally,
peroxidase-labeled secondary antibodies were used for
chemiluminescence detection.
Normalization and quantification of hNPP7ex-FLAG in
CCM
All NPP7 activity assays were performed with concen-
trated conditioned media (CCM) quantified at least
twice by western blot analysis. First, a scanning western
blot was run with varying dilutions of the CCM immedi-
ately after concentration to assess differences in the
amounts of protein in the CCM. Based on the results of
the first western blot, all samples were diluted to the
same concentration then again verified by a second
immunoblot. A known concentration of the carboxy-
terminal FLAG-BAP fusion protein from Sigma-Aldrich-
USA was included on the second western blot as a stan-
dard to quantify the amounts of protein expressed for
each sample. All protein bands were normalized relative
to the FLAG-BAP standard using the TotalLab software
program on a Fotodyne imager (Hartland, WI).
Assays of NPP7 catalytic activity
All assays of NPP7 catalytic activity were performed
three independent times with triplicate samples in each
experiment. Standard deviations of results from three
independent experiments provide error estimates.
Fluorescence-based assay
Hydrolysis of all three lipid substrates by NPP7 was
monitored using a modification of Invitrogen’s Amplex
®
Red phosphatidylcholine-specific phospholipase C assay
kit. NPP7 assay buffer was prepared as previously
described [2] containing 50 mM tris-HCl, pH 8.0, 150
mM NaCl, and 10 mM taurocholic acid but without 2
mM EDTA. Each well on the plate was loaded with a
total of 60 μL consisting of 20 μL each of substrate,
Amplex red cocktail (10 μM Amplex Red reagent, 0.1
U/mL choline oxidase, 1 U/mL horseradish peroxidase,
4 U/mL alkaline phosphatase) and normalized concen-
trations of enzyme diluted from CCM. NPP7 activity
was monitored by the level of fluorescence using excita-
tion and emission wavelengths of 571 nm and 585 nm,
respectively. Data were collected at 1 minute intervals
over a 2 hour period in a 96-well, half area plate (Corn-
ing Inc., Corning, NY) using a Synergy 2 multi-well
plate reader (BioTek, Winooski, VT, USA).
Absorbance-based assay
Hydrolysis of pNPPC was monitored using an absor-
bance assay system based on the para-nitrophenolate
product that has a maximum absorbance at 405 nm.
Each well on the plate was loaded with a total of 60 uL
consisting of 20 uL each of NPP7 assay buffer, substrate
and normalized amounts of enzyme diluted from CCM.
Table 5 Sense primers for hNPP7ex-FLAG mutations.
NPP7
mutation
Sense primer
F80A TGACCAGCC CTGCCACGCC ACCCTGGTCA
CCGGCAAATA
L107F ACCACCAGCA AGGTGAAG TTC
CCCTACCACGCCACGCTGG
Y142A TGGCTCCTTC TTCGCCCCGG GCGGGAACGT
Y166A GGCATCGCAC ACAACGCCAAAAATGAGACG
E169A TCGCAC ACAACTACAAAAATGCGACG GAGTGGAGAG
E169Q TCGCAC ACAACTACAAAAATGAGACG GAGTGGAGAG
Y194A ATCTGGTCACACTCGCCTTCGGGGAGCCGGACTCC
F275A CGGGACATCG AGTTTGAGCT CCTGGACTAC
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a t4 0 5n me v e r ym i n u t ef o ra2h o u rp e r i o di na9 6 -
well, half area plate (Corning Inc., Corning, NY) using a
Synergy 2 multi-well plate reader (BioTek, Winooski,
VT, USA).
Calculation of kinetic parameters
Relative fluorescence and absorbance units were con-
verted into product concentrations. For the fluorescence
and absorbance assays, varying concentrations of resoru-
fin or para-nitrophenol were used to generate standard
curves. The trend line equation from a plot of standard
concentration versus fluorescence/absorbance was used
to convert all relative fluorescence and absorbance units
to product concentrations. Curve fitting was done with
the kaleidograph software program to obtain Km and
Vmax.K cat was calculated using the Vmax obtained and
8.33 nM enzyme concentration used in all assays.
Results
hNPP7 homology models
Three homology models of hNPP7 were developed
using different crystallized NPP structures. Crystal
structures of a bacterial NPP were first reported in
2006 [16]. This year, additional crystallographic struc-
tures of NPP2 from two different rodent species
became available [5,6]. Notably, the bacterial NPP and
mouse NPP2 structures have been crystallized in the
presence and absence of products, AMP and LPA,
respectively. Figure 2 shows that there is essentially no
induced fit of the enzyme to these product structures.
The similarity between structures crystallized in the
presence and absence of product can be quantitated by
heavy-atom root mean square deviation (RMSD) values
for atoms within 4.5 Å of the product. The RMSD
v a l u e sa r eo n l y0 . 1 6 5Åf o rt h eb a c t e r i a lN P Pa n d
0.438 Å for the mouse NPP2. Thus either the free or
product-bound crystallographic structures should serve
equally well as a homology modeling template. Amino
acid sequence identity is similar between hNPP7 and
the three available NPP structures (24.7-25.3%). How-
ever, alignments against the available templates show
substantial differences in the number of amino acids
that align against gaps in the template structures. The
longest stretch of hNPP7 amino acids aligned against
gaps in 2GSO [16], 2XR9 [5], and 3NKM [6] were 6,
14, and 14, respectively (Figure 3). Models developed
from each template structure are shown in Figure 4,
emphasizing regions in the model that aligned against
gaps in the template structure as well as the position
of N146, a confirmed glycosylation site [14]. The long-
est gap-aligned stretches all occur in the hNPP7
sequence between P143 and E185. Due to the much
smaller gap-aligned segments in the 2GSO-based
m o d e lo fh N P P 7 ,t h i sm o d e lw a su s e di na l ld o c k i n g
studies with substrates. Two prior modeling studies of
hNPP7 also used a crystallographic structure of the
bacterial NPP as the modeling template [15,24],
although one of the studies was published prior to the
availability of the NPP2 crystal structures [15]. The
insertion of residues in the NPP7 sequence within the
segment interacting with LPA in NPP2 limits the uti-
lity of the NPP2 crystal structures as templates even
though they share a common substrate with NPP7.
Figure 2 Comparison of NPP family member crystal structures in the absence (magenta) and presence (blue) of ligand. A. Comparison
of Xac. NPP crystal structures 2GSO and 2GSU (with AMP). All-atom RMSD for residues within 4.5 Å of AMP is 0.017 Å. B. Comparison of mouse
NPP2 crystal structures 3NKM and 3NKP (with LPA). All-atom RMSD for residues within 4.5 Å of LPA is 0.44 Å. Glu308 is labeled to emphasize the
sidechain showing the largest difference between the free and bound forms of the enzyme.
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Three natural NPP7 substrates (PAF 16:0, LPC 16:0, and
SM 16:0) and one synthetic substrate (pNPPC) were
docked into the model of hNPP7. The natural substrates
were flexibly docked with shortened hydrophobic tails
and then extended manually. The synthetic substrate
was docked flexibly. The docked positions of each sub-
strate are shown in Figure 5 and 5a three dimensional
model of all four in complex with the hNPP7 homology
model are provided in additional file 1. The four com-
plexes show a common position of the choline head-
group near F275 (cation-π interaction), and a common
phosphate group position interacting strongly with one
zinc ion (chelated by D199, H203, and H353, shown to
the left in all figures) and moderately with the second
(chelated by D39, D246 and H247, shown to the right in
all figures) (ionic interactions). All four substrates
extend from the phosphate group along the bottom
edge of the parallel b-sheet bundle (van der Waals inter-
actions). Only the short acetyl sidechain of PAF 16:0
(Figure 1A) and the long palmitoyl chain of SM 16:0
(Figure 1D) extend above the edge of the parallel b-
sheet bundle (van der Waals interactions). These com-
plexes were used to select a set of mutation sites to pro-
vide experimental feedback and validation of the
models. The closest heavy atom distances from each of
these selected mutation sites to the docked substrates
are shown in Table 6. Based on these complexes, muta-
tion of F275 to a non-aromatic amino acid was expected
to result in a less active mutant against all four sub-
strates. L107 was selected for mutation to an aromatic
residue with the expectation that this could introduce a
favorable cation-π interaction with the choline group,
resulting in a more active mutant against all four sub-
strates. However, L107 also makes van der Waals con-
tact with the sphingoid chain of SM 16:0 (3.9 Å) and
the more rigid aromatic ring geometry might occlude
the space occupied by this chain. Three residues located
at various positions near the common position occupied
along the bottom edge of the parallel b-sheet bundle
were selected for mutation, including F80, Y142, and
Y166. One mutation site was selected near the chains
extending above the parallel b-sheet bundle, E169.
These latter four mutations were expected to show
Figure 3 Alignment of NPP enzyme crystal structures and hNPP7. Positions with conserved residue identity are shown in blue and marked
with asterisks. Positions with conservative substitutions are shown in green and marked with colons.
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Page 7 of 15Figure 4 Comparison of hNPP7 models based on three different template structures. Green ribbons represent hNPP7 residues aligned
against residues in the template. Magenta ribbons represent hNPP7 residues aligned against gaps in the template. Zn
2+ ions are shown as blue
spheres and the position of N146 is shown as a spacefilling model. A. hNPP7 based on PDB entry 2GSO[16] (Xac. NPP), 24.7% amino acid
identity. B. hNPP7 based on PDB entry 2XR9[5] (Rat NPP2), 24.9% amino acid identity. C. hNPP7 based on PDB entry 3NKM[6] (Mouse NPP2),
25.3% amino acid identity.
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when tested using different substrates due to the vari-
able contact distances displayed in these preliminary
docked complexes. For example, Y166 interacted closely
with the sphingoid tail of SM 16:0 (3.6 Å) but showed
negligible contact with pNPPC (7.4 Å).
hNPP7 mutations
hNPP7ExFLAG (NPP7-WT) was obtained from the
medium of transfected HEK-293T cells without further
purification. To ensure that these cells did not produce
and export proteins or factors that would interfere with
the Amplex Red assay, fluorescence readings using assay
buffer (AB), CCM from mock-transfected cells, and
CCM from NPP7-transfected cells were compared (Fig-
ure 6). Figure 6 demonstrates that only the CCM from
NPP7-transfected cells produced a fluorescent signal
using the Amplex Red assay, and only when alkaline
phosphatase was present to convert phosphocholine
produced by LPLC activity to choline. There was no
fluorescent signal in the absence of alkaline phosphatase,
eliminating any contribution to the fluorescent signal
due to direct production of choline by LPLD activity.
NPP7-WT and selected mutants were then character-
ized for their hydrolytic activity against PAF 16:0, LPA
16:0, pNPPC, and SM 16:0. The kinetic parameters
o b t a i n e df r o mt h e s ea s s a y sa r ep r o v i d e di nT a b l e s1 ,2 ,
3, and 4, and a graphical comparison of relative activity
is shown in Figure 7.
Two mutants, F275A and L107F, were selected on the
basis of their proximity to the choline headgroup of the
substrates (Table 6). Relative to NPP7-WT activities, the
F275A mutant showed either no catalytic function (LPA
16:0 and PAF 16:0), a 13-fold reduction in kcat/Km value
(pNPPC) or only a 2.2-fold reduction in kcat/Km value
(SM 16:0). These results are consistent with the models
which suggested that the F275A mutation should be
detrimental to the recognition and hydrolysis of all sub-
strates. In contrast to the consistently reduced activity
of the F275A mutant, the L107F mutant activity differed
from WT in a substrate-dependent fashion. The L107F
mutant hydrolyzed PAF 16:0, pNPPC, and LPA 16:0
Table 6 Closest distances (Å) between docked substrates
and residues selected for mutation in initial docked
complexes.
PAF 16:0
tail 1-16:0
tail 2-2:0
pNPPC LPC 16:0 SM 16:0
tail 1-sphingoid
tail 2-16:0
Choline interactions
F275 4.5 3.7 3.6 3.8
L107 7.2 7.5 5.6 8.2
Tail 1 Interactions
L107 4.5 6.2 5.1 3.9
F80 6.2 9.5 6.1 7.1
Y166 4.8 7.4 4.8 3.6
Y142 6.9 6.5 6.9 8.8
Tail 2 Interactions
E169 4.0 5.8
Figure 5 Comparison of docked substrate positions.Z n
2+ ions are shown as light blue spheres. Substrates are shown as ball & stick models.
hNPP7 residues selected for mutagenesis studies are shown as green sticks and labeled. A. PAF 16:0. B. LPC 16:0. C. pNPPC. D. SM.
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Page 9 of 15between 1.3 and 1.6 times more effectively than NPP7-
WT. Conversely, SM 16:0 was hydrolyzed 1.4 times less
effectively by L107F relative to NPP7-WT. These experi-
mental results are consistent with the model-based sug-
gestion that replacement of the nonpolar isobutyl
sidechain of leucine with the aromatic sidechain of
phenylalanine allowed formation of an additional cation-
π interaction with the substrates, but produced crowd-
ing against the SM sphingoid tail.
Three mutants, F80A, Y166A, and Y142A, were
selected on the basis of their proximity to a hydrophobic
tail in all substrates (Table 6). These mutants showed
Figure 6 Fluorescence signals from Amplex Red assays of LPC hydrolysis in the presence (grey bars) and absence (white bars) of
alkaline phosphatase using assay buffer (AB) or conditioned media from either mock or NPP7-transfected HEK293T cells.
Figure 7 Relative kcat/Km values of all mutants for hydrolysis of all substrates. Substrates include LPC (white bars), PAF16:0 (light grey bars),
pNPPC (dark grey bars) and SM (black bars). The relative kcat/Km values were obtained by dividing the kcat/Km value of each mutant with that of
wild type enzyme against the same substrate.
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Page 10 of 15opposing patterns of relative impact on SM relative to
the remaining three substrates. The Y142A mutant
showed only half the activity of the WT enzyme against
SM, but showed similar or better activity against PAF,
LPC and pNPPC (Tables 1, 2, 3, and 4). The F80A and
Y166A mutants showed reduced activity against LPC,
PAF and pNPPC, but showed similar or better activity
against SM (Tables 1, 2, 3, and 4). This pattern of activ-
ity differences was not predicted by the initial model
complexes of these substrates. However, the hydropho-
bic tails of the endogenous substrates had been placed
manually, and exploration of alternate tail positions had
been limited. Molecular dynamics simulations of LPC
16:0 and SM were therefore used to allow the substrate
tails to explore nearby low-energy placements within the
enzyme for a representative substrate from each pattern
of activity differences. Molecular dynamics simulations
showed a time-dependent alternating interaction of the
LPC 16:0 hydrophobic tail with F80 and Y166 based on
distances that oscillated between 2.5-3.0 Å and greater
than 6.5 Å (Figure 8). This result is consistent with sub-
stantially reduced activity due to mutation at either site
and suggests that the hydrophobic tail is not restricted
to a confined location, which would be an entropically
unfavorable binding contribution. Instead, the hydro-
phobic tail retains considerable flexibility within a broad
hydrophobic channel. Molecular dynamics simulations
on the SM complex provide an explanation for the
opposing impact these mutations had on hydrolysis of
SM versus LPC. In particular, the distance of the sphin-
goid tail to F80 increased during the simulation,
stabilizing at a value over 8 Å. This distance is suffi-
ciently high that minimal interactions between SM and
F80 occur, consistent with the catalytic activity similar
to WT for the F80A mutant when tested using SM as
the substrate. The SM sphingoid tail remained within
contact distance of Y142 throughout the simulation
(averaging 4.5 Å), although the closest contact involved
backbone atoms of Y142. The sidechain of Y142 forms
contacts between strands of the b-sheet as well as to a
neighboring helix. Mutation to a smaller alanine residue
m a yt h e r e f o r ea l t e rt h es h a p eo rs i z eo ft h eb i n d i n g
pocket for the second tail of SM rather than removing a
direct contact. The closest contact of the SM sphingoid
tail averaged about 2.5 Å with Y166 with a very low
standard deviation of 0.2 Å. A likely explanation for the
enhanced activity of the Y166A mutant relative to WT
for SM hydrolysis is that greater conformational flexibil-
ity of the SM sphingoid tail would be accommodated by
t h ec h a n g ef r o mab u l k yt y r o s i n et oam o r ec o m p a c t
alanine sidechain, reducing the entropic penalty of
transferring SM into the NPP7 binding pocket. Figure 8
shows a snapshot from the simulation emphasizing the
close contact with Y166 and distance from F80. The
rigid alkene portion of the sphingoid chain sits directly
above the bulky sidechain of W119 (not shown to sim-
plify view of mutated residue positions), preventing the
sphingoid chain of SM from exercising the same flexibil-
ity in the WT as the saturated sidechains of LPC 16:0
and PAF 16:0.
One mutation site, E169, was selected on the basis of
isolated contact with the second tail of PAF (short 2:0
Figure 8 LPC 16:0 position in NPP7 relative to mutated residues. Panel A. Structure shown represents an energy-minimized snapshot from
the MD simulation. Distances from sidechains to LPC 16:0 are 2.7 Å (E169 to hydroxyl), 2.9 Å (L107 to choline), 3.0 Å (F275 aromatic centroid to
choline), 3.0 Å (F80 to nonpolar tail), 7.2 Å (Y166 to nonpolar tail), and 9.0 Å (Y142 to nonpolar tail). The two distances showing the greatest
standard deviations when measured at 1 ps intervals during a 2000 ps simulation trajectory were to F80 (2.0 Å) and to Y166 (1.7 Å). Panel B.
Molecular dynamics simulations of the LPC 16:0 complex with NPP7 show dynamic motion of the nonpolar tail within the hydrophobic channel
as reflected in the distances between the nonpolar tail and the sidechains of F80 and Y166. This dynamic motion results in close interactions at
any given time point with either F80 or Y166.
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Page 11 of 15Figure 9 SM position in NPP7 relative to mutated residues. Structure shown represents an energy-minimized snapshot from the MD
simulation. Distances from sidechains to SM are 2.4 Å (Y166 to sphingoid tail), 2.5 Å (L107 to choline), 2.9Å (E169 to palmitoyl tail), 3.7 Å (F275
aromatic centroid to choline), 5.5 Å (Y142 to sphingoid tail), and 6.9 Å (F80 to sphingoid tail). Mutation of F141 (yellow) to serine was reported
by Duan, et al. to substantially reduce sphingomyelinase activity of NPP7 [15]. Distance between F141 and the palmitoyl tail is 2.8 Å.
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Page 12 of 15chain) and SM (16:0 chain). E169 was mutated to both
the similarly-sized glutamine (E169Q) and much smaller
alanine (E169A) residue. The mutation to glutamine
exhibited minimal differences from WT for LPC, PAF
and pNPPC, but showed a 1.5-fold enhanced activity
against SM. In contrast, the mutation to alanine showed
substantially decreased activity for LPC hydrolysis and
less drastic decreases for the remaining substrates. Fig-
ure 8 shows that a hydrogen bond between the free gly-
cerol hydroxyl group of LPC 16:0 and E169 forms
during the molecular dynamics simulation of the LPC
complex. This hydrogen bond could occur in the E169Q
but not in the E169A mutant. Thus, the simulation
results on the LPC complex with NPP7 are consistent
with the observed decrease in activity only of the E169A
mutant relative to WT. In contrast to the LPC complex,
Figure 9 shows that the interaction of SM with E169
predominantly involves contact between the fatty acyl
chain and the E169 sidechain. Thus enhanced activity
due to elimination of sidechain ionization in the E169Q
mutant and relatively limited activity difference in the
E169A mutant are consistent with the simulation results
on the SM complex with NPP7.
Discussion
The choline headgroups of four different substrates are
positioned consistently near F275 and L107 in prelimin-
ary homology models of NPP7 (Figure 5). The L107F
mutant was able to enhance the catalytic function of
NPP7 against three of the four substrates tested, with
reduced function only against the largest substrate due
to steric crowding (Figure 7, and Tables 1, 2, 3, and 4).
This finding was consistent with the preliminary models
which suggested a cation-π interaction might form in
the mutant to enhance interactions with the choline
groups of the three smaller substrates (Figure 5). All
other human NPP family members have a phenylalanine
at the corresponding position. The observed reduction
of SM hydrolysis upon mutation of L107 to phenylala-
nine suggests that the presence of a phenylalanine in
the other NPP family members contributes to substrate
selectivity by steric interactions with the bulkier SM
structure relative to other candidate substrates. This is
unlikely to be the sole factor determining whether an
NPP enzyme can utilize SM as a substrate as the L107F
mutant did not completely lose the ability to hydrolyze
SM. The second choline interaction site was probed
using an F275A mutant, which showed impaired cataly-
tic function against all four substrates as predicted by
the preliminary models (Figure 5 and Tables 1, 2, 3, and
4). This interaction site was previously described by
Duan, et al, in their modeling study on NPP7. [15] They
found that an F275G mutant showed almost no sphin-
gomyelinase activity, consistent with our reduced
activity of the F275A mutant. Perhaps surprisingly, an
alignment of the mammalian NPP enzymes shows
remarkable variability in the residue types that align
with F275. Neither NPP2/ATX nor NPP6 have a pheny-
lalanine aligned with F275, despite shared recognition of
phospholipids with choline headgroups. NPP2/ATX
exhibits D434 at the corresponding position, which may
form a favorable ion pair with the cationic choline head-
group instead of the cation-π interaction observed in
NPP7. NPP6 aligns Q266 against F275 of NPP7. The
role of Q266 in NPP6 will require further investigation,
since a strongly favorable interaction with the choline
headgroup is unlikely. Notably, both NPP4 and NPP5
have tyrosine residues (260 and 261, respectively) corre-
sponding to F275. Although the endogenous substrates
of NPP4 and NPP5 are unknown, the tyrosine sidechain
is capable of the same type of cation-π interaction as
the phenylalanine sidechain.
In contrast to the very high consistency between the
headgroup position in the model and experimental
mutagenesis results, the preliminary modeled positions
of the substrate tails were not uniformly consistent with
the experimental mutagenesis results. Molecular
dynamics studies indicated that the hydrophobic tails
showed dynamic interactions within a channel lined
with hydrophobic residues. This dynamic behavior
explained how mutation of F80 and Y166 to alanine
could both have detrimental impact on LPC hydrolysis
although they were unable to concurrently interact with
the LPC hydrophobic tail (Figures 7 and 8). This finding
compares well with the divergent positions of the LPA
hydrophobic tails observed in the crystallographic struc-
tures of NPP2/ATX (Figure 10) [6]. The hydrophobic
tails of LPA species in PDB [18] entries 3NKQ[6] and
3NKR [6] are located near Y214, which corresponds to
F80 in NPP7. The hydrophobic tail of the LPA species
in PDB entry 3NKP[6] contacts W275, which corre-
sponds most closely in the superposition to NPP7 resi-
d u eY 1 6 6i nt h ei n s e r t i o nl o o pf i r s td e s c r i b e db y
Nishimasu, et al. in their comparison of the bacterial
NPP and NPP2 [6]. The hydrophobic tails of LPA spe-
cies in PDB entries 3NKN[6] and 3NKO [6] are posi-
tioned intermediately between these two sidechains.
The experimental mutation results are compared in
Figure 7, and clearly demonstrate a very different pat-
t e r nf o rS Mr e l a t i v et oL P C ,P A Fa n dp N P P C ,w h i c h
show more similar profiles .S Mi st h eo n l ys u b s t r a t e
tested that has two long and flexible hydrophobic tails
(Figure 1). In our model, these tails occupy completely
different binding subpockets, above and below the con-
served b-sheet core. This prediction is in direct contrast
to the modeling studies of Duan, et al., in which both
tails were placed into the region below the conserved b-
sheet core [15]. In their homology modeling, the loop
Parrill et al. BMC Biochemistry 2011, 12:65
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Page 13 of 15segment from F140 to E171 was subjected to refinement
to generate an ensemble of loop conformations. Confor-
mations were selected for further modeling that kept
this lower binding subpocket more open to allow both
chains to fit together. Our mutation of E169Q, which
showed 1.5-fold enhanced hydrolysis of SM with rela-
tively little impact on hydrolysis of the remaining sub-
strates, suggests that the second tail of SM is not
occupying the same site as the hydrophobic tails of the
single-tail substrates, as more similarity of mutagenesis
results between SM and other substrates would be
expected. In fact, we interpret the enhanced activity of
the E169Q mutant against SM as a reduction in the
charge allowing improved hydrophobic interactions with
the second SM tail. Furthermore, Figure 9 shows that
the palmitoyl tail of SM makes close van derWaals con-
tact with the sidechain of F141, consistent with poor
sphingomyelinase activity observed for an F141S mutant
by Duan, et al., a finding that was not anticipated based
on the common positioning of the hydrophobic tails of
SM in their model below the conserved b-sheet core
[15]. Based on the current results, the F141S mutant is
likely to have activity similar to WT NPP7 against sin-
gle-tail substrates such as LPC. Importantly, as SM is
the optimal substrate for NPP7 out of those tested to
date, it is inconsistent to expect that the conformational
flexibility of the nonpolar tails would be restricted by
common occupation of a pocket of limited size due to
the unfavorable entropic contribution that the loss of
flexibility would produce. Thus several residues in the
longer insertion loop found in NPP7 relative to other
mammalian and bacterial NPP family members have
been demonstrated to play a role in substrate recogni-
tion, and likely contribute to substrate selectivity as pro-
posed by Nishimasu, et al.[ 6 ]b a s e do nt h e i r
comparison of bacterial NPP and mouse NPP2.
Conclusions
The current study has defined important differences in
recognition of SM and other phospholipid substrates of
NPP7. Two contributions to the unique activity of NPP7
against SM have been identified. First is the importance
of the amino acid at position 107. NPP7 has leucine at
this position although related NPP enzymes have pheny-
lalanine at the corresponding positions. The detrimental
impact of the NPP7-L107F mutant on hydrolysis of only
SM, compared to the positive impacts on the hydrolysis
of LPC, PAF and pNPPC supports our conclusion that
this position contributes to substrate selectivity within
the NPP family. The substrate-specific impacts of the
mutations at position E169 indicate a second contribu-
t i o nt ot h eu n i q u er e c o g n i t i o no fS M ,as e c o n dh y d r o -
phobic binding pocket for the second hydrophobic tail
that is unique to SM.
Figure 10 Crystallographic positions of LPA species in NPP2/ATX (PDB entries 3NKN, 3NKO, 3NKP, 3NKQ, 3NKR[6]).F o rc l a r i t y ,t h e
backbone of only 3NKN is represented as a ribbon colored by secondary structure (yellow for b-sheet, red for a-helix, and blue for turns) and
the zinc ions of only 3NKN are represented as cyan-colored spheres. Residues Y214 and W275 are shown as sticks due to the correspondence
with F80 and Y166 of NPP7, respectively.
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Additional file 1: Substrate complexes shown in Figure 3. Atomic
coordinates of selected homology model and initial docked complexes
of four substrates.
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